Procalcitonin (PCT) Assay Industry Journey to US$ 512.9 Million in 2033
In 2023, the procalcitonin (PCT) assay market is expected to be worth US$ 280.6 million. The market is expected to reach US$ 512.9 million by 2033, expanding at an 6.2% CAGR throughout the forecast period. Due to the rising prevalence of sepsis and infectious diseases globally has heightened the demand for accurate and reliable diagnostic tools. PCT assays have emerged as valuable biomarkers...
0 Comments
0 Shares